New support guidelines for NHS whistleblowers
February 12, 2015Medical Communications, Sales and Marketing CCG, Jeremy Hunt, NHS, comms, robert francis, whistleblowers
New guidelines to support NHS whistleblowers have been proposed by Sir Robert Francis QC – who led the inquiry into …
Apple hails health benefits of new watch
February 12, 2015Medical Communications, Sales and Marketing Apple, FDA, cook, healthkit, watch, wearables
Users of the upcoming Apple Watch will be prompted to be more active because ‘sitting is the new cancer’ according …
RSA hires three new consultants
February 12, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Beatriz de Luis, Maria-Angeles Garcia, Omar de Bary, rsa
Executive search and interims specialist firm RSA has announced three new appointments to its team of consultants in the UK. …
Pharma is boosting pipelines to avoid patent cliff
February 11, 2015Sales and Marketing Biogen IDEC, Moody's, dimethyl fumarate, lilly, pharma, pipelines, sofosbuvir, sovaldi, tecfidera
Pharmaceutical companies have improved their pipelines of new drugs over the last 18 months according to financial analysts Moody’s Investors …
US measles outbreak worst for 15 years
February 11, 2015Sales and Marketing FDA, cdcp, hamburg, measles, priorix, trimovax, vaccines
The worst measles outbreak in 15 years has reached a startling 121 cases in the US alone according to the …
GSK buys bacteria vaccine firm
February 11, 2015Research and Development, Sales and Marketing EC, GSK, GlaxoSmithKline, GlycoVaxyn, Novartis, vaccines
GlaxoSmithKline is continuing the significant expansion of its vaccine business with the purchase of Swiss biopharma company GlycoVaxyn. The UK …
MRC Technology hires senior head from Shire
February 11, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Edward Bliss, MRC, Shire
UK medical research charity MRC Technology has appointed Dr Edward Bliss to the new role of general counsel and company …
Pharma’s reputation ‘is worsening among patients’
February 10, 2015Medical Communications, Research and Development, Sales and Marketing HIV, ViiV Healthcare, patientview, pharma, reputation, transparency
Only around four in ten patients believe pharma has a good reputation and many companies are failing to win patient …
Charity challenges Sovaldi patent
February 10, 2015Sales and Marketing Gilead, HCV, Médecins du Monde, sofosbuvir, sovaldi, world health organization
Doctors of the World (also known as Médecins du Monde) has filed an opposition to the patent for Gilead’s blockbuster …
Gilead expands UK presence with new London HQ
February 10, 2015Research and Development, Sales and Marketing Cambridge, Gilead, London, NICE, UK, johnson, medcity, sovaldi, uxbridge
Gilead is to create a new UK commercial secondary headquarters in central London doubling its UK workforce to 600 by …
Second late-stage COPD trial for GSK and Theravance
February 10, 2015Sales and Marketing COPD, FF/UMEC/VI, GSK, Theravance, fluticasone furoate, umeclidinium, vilanterol
GlaxoSmithKline and Theravance have begun a second Phase III trial of their investigational triple combination COPD drug as the former …
Hospira recalls Propofol drug again
February 10, 2015Manufacturing and Production, Sales and Marketing Hospira, Pfizer, diprivan, manufacturing, merger, propofol
Hospira has issued a recall of anaesthesia support drug Propofol after the neck of one vial was revealed to contain …
Pfizer replaces UK managing director
February 10, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Erik Nordkamp, Pfizer, jonathan emms
Erik Nordkamp has been named as the managing director of Pfizer UK to take over from Jonathan Emms. Emms has …
MHRA shuts down unlicensed cancer drug facility
February 9, 2015Manufacturing and Production, Sales and Marketing Cambridge, GcMAF, MHRA, first immune, globulin component macrophage activating factor
The MHRA has shut down an unlicensed Cambridgeshire plant that was producing a potentially dangerous drug to be sold online. …
New president for ABPI
February 9, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Amgen, Pfizer, Whitehead, emms, john kearney
The Association of the British Pharmaceutical Industry has appointed John Kearney as its new president. Stepping into the role in …
FDA clears Roche eye drug
February 9, 2015Sales and Marketing AMD, DME, FDA, Lucentis, Retina, Roche, eyes, ranibizumab
The US Food and Drug Administration has shown Roche’s eye-condition drug Lucentis the green light to treat patients with diabetic …
Financial round-up: how has pharma fared in 2014?
February 9, 2015Medical Communications, Research and Development, Sales and Marketing
A select look at the latest figures and performance from some of the industry’s big players:MerckQuarter four 2014 sales Sales of …
Centogene appoints chief business officer
February 9, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Péter Adorján, centogene
Dr Péter Adorján has been appointed to the board of German rare disease firm Centogene and thereby extending its board …
Changing our minds about depression
February 9, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Campbell, Lamb, Lundbeck, depression, economist, mind
Alastair Campbell, former Labour spin doctor and depression patient, thinks that mental and physical health should not be seen as …
Sanofi sales lifted by diabetes and rare diseases
February 6, 2015Sales and Marketing Genzyme, Lantus, Sanofi, diabetes, financials, insulin glargine, praluent, q4
Sanofi racked up €7.4 billion in sales in the fourth quarter of 2014 according to the company’s latest financials report. …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
